Trials / Completed
CompletedNCT06078163
Combined Rehabilitation With ALA, ALC, Resveratrol and Vitamin D in Discogenic Sciatica in Young People
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 130 (actual)
- Sponsor
- University of Palermo · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The objective of this Interventional case-control clinical study is to evaluate the effectiveness of physiotherapy combined with the administration of Alpha Lipoic Acid, L-acetylcarnitine, Resvelatrol, Vit D3 in the treatment of sciatica due to herniated disc in young patients. The main questions we intend to answer are: * Is this combined treatment more effective in reducing pain? * Is the combined treatment useful for improving postural alterations, reducing the intake of painkillers and the number of days of absence from work and improving the quality of life?
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | supplementation | daily pharmacological therapy with Alpha Lipoic Acid 600 mg, L-acetylcarnitine 1000 mg, Resvelatrol 50 mg, vit D3 800UI for 30 consecutive days in combination with a rehabilitation protocol lasting 20 sessions |
| OTHER | rehabilitation | rehabilitation protocol lasting 20 sessions. |
Timeline
- Start date
- 2022-07-01
- Primary completion
- 2023-03-04
- Completion
- 2023-08-22
- First posted
- 2023-10-11
- Last updated
- 2023-10-11
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06078163. Inclusion in this directory is not an endorsement.